Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital (COPACNE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03465150|
Recruitment Status : Not yet recruiting
First Posted : March 14, 2018
Last Update Posted : March 22, 2018
With 24 million results associated with Google's searchon keywords "severe acne", Pr Dreno's team understand better thatthis disease, which affects many French people, is a real concern of Public Health and not a "forced evil" of the adolescent period, which will eventually resolve itself. Acne does not affect the vital prognosis, but its psychosocial impact is major and should not be underestimated. Paradoxically, despite the high prevalence of acne, few quality epidemiological studies have been published. Physicians are often helpless when faced with patients' questions. They often need a lot of explanations, especially on the factors aggravating this dermatosis, which greatly affects their quality of life.
This cohort, the first of its kind in France, will determine the predictive factors of therapeutic response, endogenous and environmental factors impacting on the severity of acne assess the quality of life and psychological impact of acne patients, determine the patient's course of care and the associated costs. Pr Dreno's team will also build up a bio collection (bacteriological samples).
|Condition or disease||Intervention/treatment|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||200 participants|
|Target Follow-Up Duration:||2 Years|
|Official Title:||Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital: the COPACNE Cohort.|
|Estimated Study Start Date :||March 30, 2018|
|Estimated Primary Completion Date :||February 28, 2033|
|Estimated Study Completion Date :||December 28, 2033|
- Other: acne
Patient with acneOther Name: acne vulgaris
- Measure of Acne stage [ Time Frame: 2 years ]composite criteria. the scale is GEA for Global Evaluation Acne Scale with 0 no acne to 5 severe acne
- assessing patients' quality of life [ Time Frame: 2 years ]composite criteria. CADI score is calculated by summing the score of each question resulting in a possible maximum of 15 and a minimum of 0. The higher the score, the more the quality of life is impaired.
- cost of acne illness [ Time Frame: 2 years ]reimbursement data relating to hospitalizations and care in town recorded by the Health Insurance in the SNIIRAM database.
- Bacteriological sample to find Propionibacterium acnes, Hormonal check-up on blood sample [ Time Frame: 2 years ]Correlation between bacterial and blood samples and the efficacity of the treatment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03465150
|Contact: Brigitte DRENOemail@example.com|
|Contact: Amir firstname.lastname@example.org|
|Principal Investigator:||Brigitte DRENO, PU-PH||CHU de Nantes|